Mustang Bio

MBIO

Mustang Bio (NASDAQ: MBIO) is a clinical-stage biopharmaceutical company founded in 2015 and headquartered in Worcester, MA, U.S. Operating as a partner company of Fortress Biotech, Mustang Bio develops CAR-T immunotherapies and gene therapies for multiple diseases, including hematologic cancers, so …

Insider trades and stock quote 2024-2026

All insider trades at Mustang Bio

Subscribe RSS
DateTypeInsiderPositionØ-PriceVolume
12/30/2025 BuyJin, David Director $1.0 $238
12/30/2025 SellChill, Adam J. Director $1.0 $4
12/30/2025 SellHerskowitz, Neil Director $1.0 $238
All information without guarantee! No recommendation/consultation! © U.S. Securities and Exchange Commission (SEC)